Success Metrics

Clinical Success Rate

57.1%

Based on 4 completed trials

Completion Rate

57%(4/7)

Active Trials

0(0%)

Results Posted

100%(4 trials)

Terminated

3(43%)

Phase Distribution

Ph phase_1

57%

Ph phase_3

14%

Ph phase_2

29%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

Phase 1Safety & dosage

4(57.1%)

Phase 2Efficacy & side effects

2(28.6%)

Phase 3Large-scale testing

1(14.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

57.1%

4 of 7 finished

Non-Completion Rate

42.9%

3 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(4)

Terminated(3)

Detailed Status

Completed4

Terminated3

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

57.1%

Most Advanced

Phase 3

Trials by Phase

Phase 14 (57.1%)

Phase 22 (28.6%)

Phase 31 (14.3%)

Trials by Status

completed457%

terminated343%

Recent Activity

0 active trials

Showing 5 of 7

completedphase_1

A Study to Evaluate Ampion in Patients With Prolonged Respiratory Symptoms Due to COVID-19 (Long COVID)

NCT04880161

terminatedphase_2

A Study of Inhaled Ampion in Adults With Respiratory Distress Due to COVID-19

NCT04868890

terminatedphase_2

Study of Intravenous Ampion in Adult COVID-19 Patients Requiring Supplemental Oxygen

NCT04839965

terminatedphase_3

Study of Ampion for the Treatment of Pain and Function in Patients With Severe Osteoarthritis of the Knee.

NCT03988023

completedphase_1

Study of Nebulized Ampion for the Treatment of Adult COVID-19 Patients With Respiratory Distress

NCT04606784

View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials

NCT04880161Phase 1

A Study to Evaluate Ampion in Patients With Prolonged Respiratory Symptoms Due to COVID-19 (Long COVID)

Completed

NCT04868890Phase 2

A Study of Inhaled Ampion in Adults With Respiratory Distress Due to COVID-19

Terminated

NCT04839965Phase 2

Study of Intravenous Ampion in Adult COVID-19 Patients Requiring Supplemental Oxygen

Terminated

NCT03988023Phase 3

Study of Ampion for the Treatment of Pain and Function in Patients With Severe Osteoarthritis of the Knee.

Terminated

NCT04606784Phase 1

Study of Nebulized Ampion for the Treatment of Adult COVID-19 Patients With Respiratory Distress

Completed

NCT04456452Phase 1

Study of Ampion for the Treatment of Adult COVID-19 Patients Requiring Oxygen Supplementation

Completed

NCT02762760Phase 1

AP-011 Study to Evaluate the Safety of a Single Intra-articular Injection of Ampion™ for Arthritis of the Basal Thumb Joint

Completed

All 7 trials loaded

Drug Details

Intervention Type: BIOLOGICAL
Total Trials: 7